- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 31.08. | Greenway Greenhouse Cannabis reports Q1 results | 2 | Seeking Alpha | ||
| 31.08. | Greenway Greenhouse Cannabis Corporation: Greenway Reports First Quarter Fiscal 2027 Financial Results | 259 | PR Newswire | KINGSVILLE, ON, Aug. 31, 2026 /PRNewswire/ -- Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) ("Greenway" or the "Company"), a cultivator of high-quality greenhouse... ► Artikel lesen | |
| 29.07. | Greenway Greenhouse Cannabis Corporation: Greenway Announces Audited Year End Financial Results | 217 | PR Newswire | Achieves Record Average Selling Price, Improved Underlying Margins and Continued Expansion of International Sales KINGSVILLE, ON, July 29, 2026 /PRNewswire/ -- Greenway Greenhouse Cannabis... ► Artikel lesen | |
| 29.05. | Greenway Greenhouse Cannabis Corp: Greenway says international sales now ~50% of revenue | 4 | Stockwatch | ||
| 28.05. | Greenway Greenhouse Cannabis Corporation: Greenway Reports Expanded International Cannabis Sales | 257 | PR Newswire | International sales now represent approximately 50% of company sales KINGSVILLE, ON, May 28, 2026 /PRNewswire/ - Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) ("Greenway"... ► Artikel lesen | |
| GREENWAY GREENHOUSE CANNABIS Aktie jetzt für 0€ handeln | |||||
| 25.02. | Greenway Greenhouse Cannabis Corporation: Greenway Announces Third Quarter Financial Statements | 386 | PR Newswire | KINGSVILLE, ON, Feb. 25, 2026 /PRNewswire/ - Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) ("Greenway" or the "Company"), a cultivator of high-quality greenhouse cannabis... ► Artikel lesen | |
| 05.01. | Greenway Greenhouse Cannabis Corporation: Greenway Reports 2025 Year In Review | 294 | PR Newswire | A year of Execution, Foundation Building, and International Expansion KINGSVILLE, ON, Jan. 5, 2026 /PRNewswire/ - Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) ("Greenway"... ► Artikel lesen | |
| 01.12.25 | Greenway Greenhouse Cannabis Corporation: Greenway Announces Second Quarter Financial Statements | 327 | PR Newswire | KINGSVILLE, ON, Dec. 1, 2025 /PRNewswire/ - Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) ("Greenway" or the "Company"), a cultivator of high-quality greenhouse cannabis... ► Artikel lesen |
8 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 49,380 | +0,14 % | Community-Rückblick: "Moderna wäre um min. 50% gestiegen, BioNTech bisher nicht mal 2%. That's it!" | © Foto: Julia Cebella - dpaNeue Onkologie-Daten sorgen bei BioNTech für Diskussionen: Warum reagiert die Aktie trotz guter Studienergebnisse kaum? Die wO User Diskutieren über Pipeline, Bewertung und... ► Artikel lesen | |
| MERCK KGAA | 133,95 | +0,75 % | Bio-Techne Shareholders Approve Acquisition By Merck As U.S. Antitrust Waiting Period Expires | ||
| NOVO NORDISK | 33,680 | -0,49 % | Umsatzschub zündet!: Rekordumsatz! Dieser Micro-Cap übertrifft nach acht Monaten bereits das gesamte Vorjahr | ||
| ETON PHARMACEUTICALS | 59,49 | 0,00 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DexCom, Oruka Therapeutics, Concentra Group Holdings Parent, AtaiBeckley | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 15,990 | 0,00 % | Generate Biomedicines auf dem Bernstein Healthcare Forum: Daten statt Modelle | ||
| PFIZER | 25,090 | +1,41 % | Eli Lilly und Novo Nordisk bekommen neue Konkurrenz - warum der 100-Milliarden-Dollar-Markt immer mehr Biotech-Unternehmen anzieht | ||
| SCHOTT PHARMA | 24,600 | +3,36 % | Schott Pharma: Was JPMorgans Kaufvotum jetzt auslöst | ||
| KARDIGAN | 14,390 | 0,00 % | Citi's U.S. Consumer Cards Business To Buy Kard Financial For Undisclosed Terms | WASHINGTON (dpa-AFX) - Banking major Citigroup Inc. (C) announced late Thursday that its U.S. Consumer Cards business has agreed to acquire Kard Financial, a commerce media and rewards platform.... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,820 | 0,00 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm (dibutepinephrine) Sublingual Film | Resubmission supported by positive topline human factors and pharmacokinetic (PK) study results announced in August 2026FDA will determine the resubmission classification and establish the applicable... ► Artikel lesen | |
| LB PHARMACEUTICALS | 37,790 | -0,03 % | LB Pharmaceuticals auf TD Cowen Summit: Wirkstoffkandidat LB-102 zielt auf sicherere psychiatrische Behandlungen ab | ||
| ELI LILLY | 1.029,60 | +1,74 % | Lilly Again Looks to China for New Drugs, Paying InnoCare $100M to Start R&D Pact | ||
| JAGUAR HEALTH | 7,010 | -0,71 % | Morning Market Movers: Wheeler REIT, Professional Diversity Network, Jaguar Health, Greenland Mines See Big Swings | BEIJING (dpa-AFX) - At 6:50 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| KAZIA THERAPEUTICS | 9,690 | -0,92 % | Kazia Therapeutics Limited: Kazia Therapeutics Announces Sovargen Co. Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders | Clinical Milestone Expands Development of Paxalisib Beyond Oncology and Triggers $2 Million Payment to Kazia
SYDNEY, Sept. 22, 2026 /PRNewswire/ -- Kazia Therapeutics... ► Artikel lesen | |
| DERMAPHARM | 39,300 | +0,13 % | JEFFERIES stuft Dermapharm auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Dermapharm nach einem Treffen mit dem Finanzchef Christof Dreibholz mit einem Kursziel von 44 Euro auf "Hold" belassen.... ► Artikel lesen | |
| OMNIAB | 4,800 | 0,00 % | Veraxa Biotech AG: VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb | VXA-222 advances into next phase at VERAXAZURICH, SWITZERLAND, July 27, 2026 --
VERAXA Biotech AG (NASDAQ: VRXA; "VERAXA" or the "Company"), an emerging leader in designing novel cancer therapies... ► Artikel lesen |
GREENWAY GREENHOUSE CANNABIS CORPORATION gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GREENWAY GREENHOUSE CANNABIS CORPORATION finden Sie auf Wallstreet Online.